Persistent Asset Partners »

Crispr Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7k 270 10.09

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics